EDMONTON, Alberta, March 19 /PRNewswire-FirstCall/ -- Medical Services International Inc. (Pinksheets: MSITF - News) is pleased to announce that it has agreed to a assembly/production facility with a Company based in Shanghai, People's Republic of China. The Agreement is in the form of a joint venture to bring an assembly/manufacturing plant on line to produce VScan rapid test kits in China. The Shanghai based Company would supply the building and labor while Medical Services would supply the technology and training. The proprietary technology will remain the property of Medical Services and the component related to this technology would continue to be manufactured in Medical Services facilities. The Joint Venture would be a 50/50 partnership. This facility would have the capability of producing 4 to 5 million kits per year. The joint venture would result in a substantial reduction in costs related to duties, taxes and shipping. A China based production facility would receive very favorable consideration in all Chinese markets.

 

ADVERTISEMENT

About VScan

The VScan rapid test kit is a single use, easy to use, test for the screening of HIV 1&2 and subgroup O, Hepatitis B&C, Tuberculosis (TB) and West Nile. The kits cannot be sold in Canada.

Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or Bill Whitehead Jr. at (416) 822 5883 or www.medicalservicesintl.com.

NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition, and other factors described in Company reports and other filings with regulatory bodies.